ReviewAnnals of the New York Academy of Sciences2013

Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma.

Jedd D Wolchok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.